Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.705
-0.010-1.40%
Volume:35.27M
Turnover:25.23M
Market Cap:6.43B
PE:35.79
High:0.730
Open:0.720
Low:0.705
Close:0.715
52wk High:1.896
52wk Low:0.685
Shares:9.12B
HK Float Shares:9.12B
Volume Ratio:2.34
T/O Rate:0.39%
Dividend:0.01
Dividend Rate:1.59%
EPS(LYR):0.020
ROE:5.57%
ROA:2.80%
PB:0.89
PE(LYR):35.79
PS:2.09

Loading ...

Xuanzhu Biopharma Says NMPA Accepts NDA for Anaprazole Sodium in Reflux Esophagitis

Reuters
·
Jun 30

Sihuan Pharmaceutical AGM Clears All Resolutions; Final Dividend Set at HK1.09 Cents per Share

Bulletin Express
·
Jun 26

Sihuan Pharmaceutical Shareholders Approve RMB 0.96 Cent Final Dividend for 2025

Reuters
·
Jun 26

Sihuan Pharmaceutical launches Phase III trial of Anaprazole Sodium for Helicobacter pylori eradication

Bulletin Express
·
Jun 22

Xuanzhu Biopharma enrolls first patient in Phase III trial of anaprazole sodium for H. pylori eradication

Reuters
·
Jun 21

Xuanzhu Biopharmaceutical files director list with Hong Kong Stock Exchange

Reuters
·
Jun 18

Xuanzhu Biopharma names Yue Xin employee representative director after election

Reuters
·
Jun 18

SIHUAN PHARM Purchases 5 Million Shares for Incentive Scheme

Stock News
·
Jun 08

Sihuan Pharmaceutical Buys 5.00 Million Shares for Award Scheme After 37.7% Revenue Surge

Bulletin Express
·
Jun 08

SIHUAN PHARM Purchases 10 Million Shares for Incentive Scheme via Trustee

Stock News
·
Jun 03

Sihuan Pharma trustee buys 10 million shares for employee share award scheme at HK$0.95 each

Reuters
·
Jun 03

Sihuan Pharma Publishes AGM Circular and Switches to E-Communication for Non-Registered Shareholders

Bulletin Express
·
Jun 02

Sihuan Pharma Releases AGM Circular and Proxy Form; Shareholders May Update Communication Preferences

Bulletin Express
·
Jun 02

Sihuan Pharmaceutical announces annual shareholder meeting

Reuters
·
Jun 02

Sihuan Pharm Cuts Outstanding Shares by 20 Million in May Buybacks; Public Float Remains Compliant

Bulletin Express
·
Jun 01

Sihuan Pharmaceutical to Form AI-Powered Medical Aesthetics JV with dProtein, Takes Strategic Stake in Partner’s Pre-A Financing

Bulletin Express
·
May 28

SIHUAN PHARM (00460) Signs Cooperation Agreement with Shenyuan Zhiyao to Deepen Strategic AI Deployment Across Medical Aesthetics and Drug R&D

Stock News
·
May 28

Sihuan Pharma signs cooperation deal with dProtein to form AI-focused medical aesthetics JV

Reuters
·
May 28

Sihuan Pharma - Becomes Strategic Investor in Dprotein's Pre-a Financing

THOMSON REUTERS
·
May 28

Sihuan Pharma - Co and Dprotein to Form Joint Venture Company

THOMSON REUTERS
·
May 28